ZA938959B - Alpha, omega-diaralaikane derivatives,their preparation and their use in the treatment and prevention of circulatory diseases and psychosis - Google Patents

Alpha, omega-diaralaikane derivatives,their preparation and their use in the treatment and prevention of circulatory diseases and psychosis

Info

Publication number
ZA938959B
ZA938959B ZA938959A ZA938959A ZA938959B ZA 938959 B ZA938959 B ZA 938959B ZA 938959 A ZA938959 A ZA 938959A ZA 938959 A ZA938959 A ZA 938959A ZA 938959 B ZA938959 B ZA 938959B
Authority
ZA
South Africa
Prior art keywords
diaralaikane
psychosis
omega
alpha
prevention
Prior art date
Application number
ZA938959A
Inventor
Koichi Fujimoto
Naoki Tanaka
Fumitoshi Asai
Tomiyoshi Ito
Hiroyuki Koike
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of ZA938959B publication Critical patent/ZA938959B/en

Links

ZA938959A 1992-11-30 1993-11-30 Alpha, omega-diaralaikane derivatives,their preparation and their use in the treatment and prevention of circulatory diseases and psychosis ZA938959B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32060992 1992-11-30

Publications (1)

Publication Number Publication Date
ZA938959B true ZA938959B (en) 1994-08-03

Family

ID=18123318

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA938959A ZA938959B (en) 1992-11-30 1993-11-30 Alpha, omega-diaralaikane derivatives,their preparation and their use in the treatment and prevention of circulatory diseases and psychosis

Country Status (1)

Country Link
ZA (1) ZA938959B (en)

Similar Documents

Publication Publication Date Title
AU2326892A (en) Acylmercaptoalkanoyldipeptides, methods of preparation and their therapeutic use
GB9518115D0 (en) Triazole derivatives and their use as therapeutic agents
NZ241211A (en) 16alpha,17alpha-alkylidenedioxy-11b,21-dihydroxypregan -4-ene-3,20-dione derivatives substituted by halogen in either or both of the 6alpha- or the 9alpha- position; pharmaceutical compositions, methods of preparation and treatment
IL99612A0 (en) 2-aminopyrimidine-4-carboxamide derivatives,their preparation and their use in therapy
ZA871528B (en) The treatment of diseases of the immune system with diphenylhydantoin and its derivatives
GB9219425D0 (en) Therapeutic agent and its use
AU5201793A (en) Alpha, omega-diarylalkane derivatives, their preparation and their use in the treatment and prevention of circulatory diseases and psychosis
GB9321341D0 (en) Therapeutic compositions for use in the treatment of skin lesions and method of making same
AU1898792A (en) Treatment or therapeutic booth for energetic, cosmetic and medical purposes
IL91451A0 (en) Pharmaceutical compositions comprising azapiron compounds and their use in the treatment of addiction
ZA938959B (en) Alpha, omega-diaralaikane derivatives,their preparation and their use in the treatment and prevention of circulatory diseases and psychosis
EP0427427A3 (en) Use of arylalkylamides in the treatment of neurodegenerative diseases
SG47098A1 (en) Diamines in the treatment of arrhythmia
GB9111885D0 (en) Nerve growth factor for use in the prevention and treatment of viral infections
GB2279567B (en) Compositions for the treatment of inflammatory proliferative skin disease and their use
AU641157B2 (en) 2-imino-thiadiazoline-5-sulphonamides and their use in the treatment of glaucoma
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
ZA899304B (en) Use of benzopyran derivatives in the treatment of epilepsy
GB9010190D0 (en) Composition for the treatment of protozoal disease and their use
EP0456204A3 (en) Use of benzocycloheptathiophenecarboxylic acid derivatives in the treatment of eosinophile accumulation/activation and connected diseases
AU2153092A (en) Spirofurane derivatives and their use in the treatment of neurological disorders
EP0452941A3 (en) Use of isomonools in the treatment and prophylaxis of cancer
ZA939333B (en) 3-(6-quinolylmethyl)-4H-imidazol-4-one derivatives their preparation and their application in therapy
AU4066993A (en) Para-substituted benzyl amines and their use as antimycotics and for the treatment of cardiac and circulatory diseases
EP0576953A3 (en) Production of human cathepsin and its use.